BioSpace News Archive

Business

Generex Announces Results of Annual Stockholders’ Meeting

Brian McGee, Dr. James H. Anderson, Jr., MD, Dr. Craig Eagle, MD, and Dr. Gary H. Lyman, MD, MPH were elected as independent members of the Company’s Board of Directors.

November 27, 2017

·

4 min read

Business

Fresenius Medical Care Achieves Improved Health Outcomes and Savings Through National Medicare Demonstration Program

This success was validated by an independent report from Lewin Group, which showed a nearly nine percent decrease in hospitalization rates for these patients during the same time.

November 27, 2017

·

4 min read

Lone Star Bio

Acelity: New Independent Study Results Add to Growing Body of Evidence That PREVENA Therapy Helps Reduce Surgical Site Infections and Complications

Study concludes that total arthroplasty patients treated with PREVENA Therapy were four times less likely to experience surgical site complications compared with traditional gauze dressing.

November 27, 2017

·

6 min read

Bio-Tissue Announces Study that Demonstrates Cryopreserved Amniotic Membrane Graft Reduces Recurrence After Pterygium Surgery

In this retrospective review, 556 eyes representing 535 patients, who had pterygium excision (527 primary, 29 recurrent) were treated with adjunctive cryopreserved amniotic membrane.

November 27, 2017

·

2 min read

Business

South Africa’s CPGR to Partner With The Sunflower Fund to stimulate Medical Innovation in Africa Through Access to High-Resolution HLA Testing and Data Aggregation

The CPGR today announced that it has entered into a partnership with TSF to make best-in-class stem-cell typing solutions available on the African continent.

November 27, 2017

·

5 min read

European Patent Office Grants to ASIT Biotech a Second Patent Related to the Active Ingredients Used in the ASIT+ Allergy Immunotherapy Product Candidates

The grant will be effective from November 29, 2017 until June 15, 2032 with a possible extension of 5 years via a supplementary protection certificate.

November 27, 2017

·

5 min read

Drug Development

TG Therapeutics Announces Initiation of National Cancer Institute/SWOG-Sponsored Randomized Phase II Trial in Follicular Lymphoma

TGR-1202 (umbralisib) selected as the PI3K Delta inhibitor to be used in this multiple arm comparison study

November 27, 2017

·

5 min read

Deals

Beckman Coulter Enters Commercial Dispute With Quidel to Sell BNP Directly

To further these goals, Beckman Coulter plans in the future to sell directly to its customers a natriuretic peptide assay for its Access Family of Immunoassay Systems.

November 27, 2017

·

1 min read

BASF to Increase Prices for Formic Acid and Propionic Acid in the EMEA Region

Prices for all other concentrations of Formic Acid will be increased accordingly on a pro rata basis.

November 27, 2017

·

1 min read

Drug Development

Novartis’ Ultibro Breezhaler Significantly Improved COPD Patients’ Lung Function After Direct Switch From Seretide

The study met the primary endpoint demonstrating that switching patients to Ultibro Breezhaler resulted in significantly improved lung function (trough FEV1)[1].

November 27, 2017

·

11 min read